SGLT2 inhibitor therapy provided protective effects from cardiovascular (CV) events in patients with type 2 diabetes with or without established CV disease.
Eli Lilly plans to donate at least 200,000 KwikPens of its insulin to support lower-income communities.
WHO declares the 2019 novel coronavirus outbreak a global emergency as first person-to-person transmission occurs in US.
Amlodipine lowered the risk of gout when compared with 2 other antihypertensive medications.
OptumRx’s most recent pipeline outlook for 2020 reveals key therapeutic areas in the lineup.
Officials with the FDA have approved ferric derisomaltose (Monoferric, Pharmacosmos Therapeutics Inc.) injection 100 mg/mL.
A pharmacy group is taking a wait-and-see approach after California Governor Gavin Newsom (D) announced several drug reforms–including a state generic prescription drug label.
Alkermes is seeking FDA approval for its investigational antipsychotic drug candidate ALKS 3831 for schizophrenia and bipolar I disorder.
Data tracked by wearable fitness sensors may help with real-time surveillance of seasonal respiratory infections, such as influenza.
How the pharmacy team at Novant Health Brunswick Medical Center ensured patients got their medications during Hurricane Florence.